Here, we interestingly find that hepatocarcinogenesis phenotypes modulated by hepatocyte-specific RIG-I deficiency are inverse in two commonly used mouse models, which are RIG-I promotes STAM HCC representing NASH-induced carcinogenesis whereas suppresses DEN-induced inflammation and carcinogenesis. This evidence concerns the gene RIGI and metabolic dysfunction-associated steatohepatitis.